Patent details

EP3122358 Title: COMBINATIONS OF FGFR- AND CMET-INHIBITORS FOR THE TREATMENT OF CANCER

Basic Information

Publication number:
EP3122358
PCT Application Number:
EP2015056512
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157211293
PCT Publication Number:
WO2015144804
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATIONS OF FGFR- AND CMET-INHIBITORS FOR THE TREATMENT OF CANCER
French Title of Invention:
COMBINAISONS DES INHIBITEURS DU FGFR ET DU CMET DESTINÉES AU TRAITEMENT DU CANCER
German Title of Invention:
KOMBINATIONEN AUS FGFR- UND CMET-HEMMER ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
26/03/2015
Grant date:
16/12/2020
EP Publication Date:
01/02/2017
PCT Publication Date:
01/10/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/12/2020
EP B1 Publication Date:
16/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/03/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/12/2020
 
 

Name:
Astex Therapeutics Ltd.
Address:
436 Cambridge Science Park Milton Road, Cambridge CB4 0QA, United Kingdom (GB)

Agent

Name:
HERNANDEZ IP
From:
15/02/2021
Address:
Ludwig-Ganghofer-Str. 42, 82031, Grünwald, Germany (DE)
To:

Inventor

1

Name:
PERERA, Timothy Pietro Suren
Address:
Belgium (BE)

2

Name:
JOVCHEVA, Eleonora
Address:
Belgium (BE)

Priority

Priority Number:
14161835
Priority Date:
26/03/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/498; A61K 31/4985; A61K 31/5025; A61P 35/00; A61P 43/00;

Publication

European Patent Bulletin

1

Issue number:
202051
Publication date:
16/12/2020
Description:
Grant (B1)

2

Issue number:
202103
Publication date:
20/01/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/03/2026
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CLARIVATE IP SERVICES LIMITED
Filing date Document type Number of pages
16/02/2021 Outgoing Correspondence 1
15/02/2021 Power Of Attorney 1